113 related articles for article (PubMed ID: 8297214)
1. Clinical response to clozapine in patients with schizophrenia.
Pickar D; Litman RE; Hong WW; Su TP; Weissman EM; Hsiao JK; Potter WZ
Arch Gen Psychiatry; 1994 Feb; 51(2):159-60. PubMed ID: 8297214
[No Abstract] [Full Text] [Related]
2. Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study.
Litman RE; Hong WW; Weissman EM; Su TP; Potter WZ; Pickar D
J Clin Psychopharmacol; 1993 Aug; 13(4):264-7. PubMed ID: 8104200
[TBL] [Abstract][Full Text] [Related]
3. Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine.
Litman RE; Su TP; Potter WZ; Hong WW; Pickar D
Br J Psychiatry; 1996 May; 168(5):571-9. PubMed ID: 8733795
[TBL] [Abstract][Full Text] [Related]
4. Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia.
Litman RE; Hommer DW; Radant A; Clem T; Pickar D
Schizophr Res; 1994 May; 12(2):107-20. PubMed ID: 8043521
[TBL] [Abstract][Full Text] [Related]
5. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
[TBL] [Abstract][Full Text] [Related]
6. One-year follow-up of 24 patients in a clinical trial of clozapine.
Davies MA; Conley RR; Schulz SC; Bell-Delaney J
Hosp Community Psychiatry; 1991 Jun; 42(6):628-9. PubMed ID: 1864575
[No Abstract] [Full Text] [Related]
7. Clozapine as a first treatment for schizophrenia.
Woerner MG; Robinson DG; Alvir JM; Sheitman BB; Lieberman JA; Kane JM
Am J Psychiatry; 2003 Aug; 160(8):1514-6. PubMed ID: 12900316
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.
Pickar D; Owen RR; Litman RE; Konicki E; Gutierrez R; Rapaport MH
Arch Gen Psychiatry; 1992 May; 49(5):345-53. PubMed ID: 1375019
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine augmentation of clozapine treatment in patients with schizophrenia.
Buchanan RW; Kirkpatrick B; Bryant N; Ball P; Breier A
Am J Psychiatry; 1996 Dec; 153(12):1625-7. PubMed ID: 8942462
[TBL] [Abstract][Full Text] [Related]
10. Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine.
Zahn TP; Pickar D
Biol Psychiatry; 1993 Jul 1-15; 34(1-2):3-12. PubMed ID: 8104043
[TBL] [Abstract][Full Text] [Related]
11. [Is there a special indication for fluphenazine in therapy refractory hallucinations?].
Bechter K
Nervenarzt; 1994 Nov; 65(11):798-801. PubMed ID: 7816159
[TBL] [Abstract][Full Text] [Related]
12. Clozapine decreases smoking in patients with chronic schizophrenia.
McEvoy J; Freudenreich O; McGee M; VanderZwaag C; Levin E; Rose J
Biol Psychiatry; 1995 Apr; 37(8):550-2. PubMed ID: 7619979
[No Abstract] [Full Text] [Related]
13. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.
Cohen RM; Nordahl TE; Semple WE; Andreason P; Litman RE; Pickar D
Arch Gen Psychiatry; 1997 May; 54(5):481-6. PubMed ID: 9152102
[TBL] [Abstract][Full Text] [Related]
14. Stability of neurological signs with clozapine treatment.
Buchanan RW; Koeppl P; Breier A
Biol Psychiatry; 1994 Aug; 36(3):198-200. PubMed ID: 7948457
[No Abstract] [Full Text] [Related]
15. Acute tryptophan depletion in schizophrenic patients treated with clozapine.
George TP; Potenza MN; Degen K; Sernyak MJ; Woods S; McDougle CJ
Arch Gen Psychiatry; 2002 Mar; 59(3):291-2. PubMed ID: 11879174
[No Abstract] [Full Text] [Related]
16. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D
Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
[TBL] [Abstract][Full Text] [Related]
17. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia.
Wolkowitz OM; Pickar D; Doran AR; Breier A; Tarell J; Paul SM
Am J Psychiatry; 1986 Jan; 143(1):85-7. PubMed ID: 2867690
[TBL] [Abstract][Full Text] [Related]
18. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
Odejide OA; Aderounmu AF
J Clin Psychiatry; 1982 May; 43(5):195-6. PubMed ID: 7076630
[TBL] [Abstract][Full Text] [Related]
19. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
[TBL] [Abstract][Full Text] [Related]
20. Clozapine augmented with aripiprazole in 5 patients with schizophrenia.
Abu-Tair F; Kopitz J; Bergemann N
J Clin Psychopharmacol; 2006 Dec; 26(6):669-71. PubMed ID: 17110831
[No Abstract] [Full Text] [Related]
[Next] [New Search]
